RankAlpha logo
Back to Rankings

AQST

Aquestive TherapeuticsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-16
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
AQST vs peer average
26/100
AQST vs. peer average (F vs. C)
Grade spread
B 2 · C 2 · D 2 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

DNA is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $522.6M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerDNAGinkgo Bioworks
AQST
Aquestive Therapeutics
DNA
Ginkgo Bioworks
Grade
F
D
Momentum
32
47
Value
41
41
Sentiment
-
40
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs DNA

AQST / DNA
Grade Position
Below peers
AQST vs. peer average (F vs. C)
26/100
Momentum
32
DNA
Value
41
AQST
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs AQST
1
DNA
Ginkgo Bioworks Holdings Inc Class A Common
D
40/100
-1
2
CTKB
Cytek Biosciences Inc Common
C
60/100
-2
3
PRME
Prime Medicine Inc Common
F
20/100
Even
4
MDXG
MiMedx Group Inc Common
D
40/100
-1
5
CBIO
Crescent Biopharma Inc Common
B
80/100
-3
DNA is the first peer returned for this comparison set.